Flaxseed powder and magnesium hydroxide syrup on the intestinal function of patients with acute myocardial infarction in intensive care units
- PMID: 38807721
- PMCID: PMC11129063
- DOI: 10.22088/cjim.15.2.234
Flaxseed powder and magnesium hydroxide syrup on the intestinal function of patients with acute myocardial infarction in intensive care units
Abstract
Background: Flaxseed powder seems to improve bowel movements in these patients. Therefore, this study compares the effects of flaxseed powder and magnesium hydroxide on bowel movements of acute myocardial infarction patients hospitalized in ICU.
Methods: The population of the present parallel randomized controlled clinical trial included 70 acute myocardial infarction patients hospitalized in ICU who had no history of chronic constipation. The patients in the intervention group were given three sachets of flaxseed powder (each sachet was 3 g) twice a day for four days. The patients in the control group were given 20 cc of magnesium hydroxide syrup each morning. The Bristol scale was used to describe stool consistency.
Results: The mean and standard deviation of the number of bowel movements within five days after intervention are 1.86 ± 1.08 and 1.6 ± 0.65 in the intervention and the control groups, respectively. The frequency of normal stool consistency of the first bowel movement is 94.3% for the intervention group and 85.7% for the control group, which shows no significant differences between the two groups in terms of stool consistency and bowel movement frequency (P=0.510). The bowel movements started on average after 35.2±97.97 hours in the flaxseed group and 24.771±2.677 hours in the magnesium hydroxide group (P=0.023).
Conclusion: The results showed that flaxseed powder increases bowel movement frequency and improves the patients' stool consistency, but the differences between the two groups are insignificant. Finally, the time to the first defecation was shorter in the magnesium hydroxide group.
Keywords: Acute myocardial infarction; Constipation.; Flaxseed; Intestinal function; Magnesium hydroxide syrup; powder.
© The Author(s).
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Effects of flaxseed supplementation on functional constipation and quality of life in a Chinese population: A randomized trial.Asia Pac J Clin Nutr. 2020;29(1):61-67. doi: 10.6133/apjcn.202003_29(1).0009. Asia Pac J Clin Nutr. 2020. PMID: 32229443 Clinical Trial.
-
Efficacy of oral magnesium therapy in the treatment of chronic constipation in spastic cerebral palsy children: a randomized controlled trial.World J Pediatr. 2021 Feb;17(1):92-98. doi: 10.1007/s12519-020-00401-0. Epub 2021 Jan 22. World J Pediatr. 2021. PMID: 33481179 Clinical Trial.
-
Effects of acupressure on intestinal function in patients with coronary artery bypass graft surgery: a randomized clinical trial.Gastroenterol Hepatol Bed Bench. 2023;16(3):282-291. doi: 10.22037/ghfbb.v16i2.2720. Gastroenterol Hepatol Bed Bench. 2023. PMID: 37767324 Free PMC article.
-
Interventions for preventing postpartum constipation.Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD011625. doi: 10.1002/14651858.CD011625.pub3. Cochrane Database Syst Rev. 2020. PMID: 32761813 Free PMC article.
-
The effect of food, vitamin, or mineral supplements on chronic constipation in adults: A systematic review and meta-analysis of randomized controlled trials.Neurogastroenterol Motil. 2023 Nov;35(11):e14613. doi: 10.1111/nmo.14613. Epub 2023 May 27. Neurogastroenterol Motil. 2023. PMID: 37243443
References
-
- Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197–210. - PubMed
-
- Prat D, Messika J, Avenel A, et al. Constipation incidence and impact in medical critical care patients: importance of the definition criterion. Eur J Gastroenterol Hepatol. 2016;28:290–6. - PubMed
-
- Rao SS, Rattanakovit K, Patcharatrakul T. Diagnosis and management of chronic constipation in adults. Nat Rev Gastroenterol Hepatol. 2016;13:295–305. - PubMed
-
- Müller‐Lissner S, Rykx A, Kerstens R, Vandeplassche L. A double‐blind, placebo‐controlled study of prucalopride in elderly patients with chronic constipation. Neurogastroenterol Motil. 2010;22:991–255. - PubMed
LinkOut - more resources
Full Text Sources